申请人:Aurobindo Pharma Ltd.
公开号:US20210002207A1
公开(公告)日:2021-01-07
The present invention provides a process for the preparation of vigabatrin of formula (I) comprising of dissolving vigabatrin in water, optionally treating with charcoal, filtering and adding an acid to the reaction mass followed by the addition of an organic solvent and then isolating vigabatrin of formula (I) with high purity.